Maternal immunisation: collaborating with mother nature

The Lancet Infectious Diseases

Volumn 17, Issue 7, 2017, Pages e197-e208

  Marchant, Arnaud ^a   Sadarangani, Manish ^b,c   Garand, Mathieu ^c,d   Dauby, Nicolas ^a,e   Verhasselt, Valerie ^f   Pereira, Lenore ^g   Bjornson, Gordean ^c   Jones, Christine E ^h   Halperin, Scott A ^h   Edwards, Kathryn M ^j   Heath, Paul ⁱ   Openshaw, Peter J ^k   Scheifele, David W ^c   Kollmann, Tobias R ^c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^j VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^k NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MATERNAL ANTIBODY; INFLUENZA VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; STREPTOCOCCUS VACCINE;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BREAST FEEDING; BREAST MILK; CONSULTATION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNITY; INFLUENZA; INFLUENZA VIRUS; LEUKOCYTE; MATERNAL CARE; NATIONAL HEALTH ORGANIZATION; PASSIVE IMMUNIZATION; PERTUSSIS; PLACENTA; PREGNANCY; PREMATURE LABOR; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RESEARCH PRIORITY; REVIEW; STREPTOCOCCUS AGALACTIAE; DEVELOPING COUNTRY; FEMALE; GLOBAL HEALTH; IMMUNIZATION; IMMUNOLOGY; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROCEDURES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; STREPTOCOCCAL INFECTIONS; UTILIZATION;

DEVELOPING COUNTRIES; FEMALE; GLOBAL HEALTH; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE;

EID: 85018535089     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30229-3     Document Type: Review

References (159)

1. Lawn, JE, Blencowe, H, Oza, S, et al. Every Newborn: progress, priorities, and potential beyond survival. Lancet 384 (2014), 189–205.
2. Laenen, J, Roelants, M, Devlieger, R, Vandermeulen, C, Influenza and pertussis vaccination coverage in pregnant women. Vaccine 33 (2015), 2125–2131.
3. Abu Raya, B, Edwards, KM, Scheifele, DW, Halperin, SA, Pertussis and influenza immunisation during pregnancy: a landscape review. Lancet Infect Dis, 2017 published online April 19 http://dx.doi.org/10.1016/S1473-3099(17)30190-1.
4. Heath, PT, Culley, FJ, Jones, CE, et al. Group B streptococcus and respiratory syncytial virus immunisation during pregnancy. Lancet Infect Dis, 2017 published online April 19 http://dx.doi.org/10.1016S1473-3099(17)30232-3.
5. Beigi, RH, Fortner, KB, Munoz, FM, et al. Maternal immunisation: opportunities for scientific advancement. Clin Infect Dis 59:suppl 7 (2014), S408–S414.
6. Medina, KL, Kincade, PW, Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci USA 91 (1994), 5382–5386.
7. Mahmoud, F, Abul, H, Omu, A, Al-Rayes, S, Haines, D, Whaley, K, Pregnancy-associated changes in peripheral blood lymphocyte subpopulations in normal Kuwaiti women. Gynecol Obstet Invest 52 (2000), 232–236.
8. Zimmer, JP, Garza, C, Butte, NF, Goldman, AS, Maternal blood B-cell (CD19+) percentages and serum immunoglobulin concentrations correlate with breast-feeding behavior and serum prolactin concentration. Am J Reprod Immunol 40 (1998), 57–62.
9. Matthiesen, L, Berg, G, Ernerudh, J, Håkansson, L, Lymphocyte subsets and mitogen stimulation of blood lymphocytes in preeclampsia. Am J Reprod Immunol 41 (1989), 192–203.
10. Ampomah, P, Stevenson, L, Ofori, MF, Barfod, L, Hviid, L, Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites. J Immunol 192 (2014), 5236–5244.
11. Requena, P, Campo, JJ, Umbers, AJ, et al. Pregnancy and malaria exposure are associated with changes in the B cell pool and in plasma eotaxin levels. J Immunol 193 (2014), 2971–2983.
12. Dauby, N, Kummert, C, Lecomte, S, et al. Primary human cytomegalovirus infection induces the expansion of virus-specific activated and atypical memory B cells. J Infect Dis 210 (2014), 1275–1285.
13. Kanda, N, Tamaki, K, Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 103 (1999), 282–288.
14. Correale, J, Farez, MF, Ysrraelit, MC, Role of prolactin in B cell regulation in multiple sclerosis. J Neuroimmunol 269 (2014), 76–86.
15. Pauklin, S, Sernández, IV, Bachmann, G, Ramiro, AR, Petersen-Mahrt, SK, Estrogen directly activates AID transcription and function. J Exp Med 206 (2009), 99–111.
16. McGregor, IA, Rowe, DS, Wilson, ME, Billewicz, WZ, Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol 7 (1970), 51–74.
17. Amino, N, Tanizawa, O, Miyai, K, et al. Changes of serum immunoglobulins IgG, IgA, IgM, and IgE during pregnancy. Obstet Gynecol 52 (1978), 415–420.
18. Bondt, A, Rombouts, Y, Selman, MHJ, et al. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol Cell Proteomics 13 (2014), 3029–3039.
19. Pincetic, A, Bournazos, S, DiLillo, DJ, et al. Type I and type II Fc receptors regulate innate and adaptive immunity. Nat Immunol 15 (2014), 707–716.
20. Bondt, A, Selman, MHJ, Deelder, AM, et al. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J Proteome Res 12 (2013), 4522–4531.
21. Ackerman, ME, Crispin, M, Yu, X, et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest 123 (2013), 2183–2192.
22. Mahan, AE, Jennewein, MF, Suscovich, T, et al. Antigen-specific antibody glycosylation is regulated via vaccination. PLoS Pathog, 12, 2016, e1005456.
23. Yoshimura, T, Inaba, M, Sugiura, K, et al. Analyses of dendritic cell subsets in pregnancy. Am J Reprod Immunol 50 (1989), 137–145.
24. Della Bella, S, Giannelli, S, Cozzi, V, et al. Incomplete activation of peripheral blood dendritic cells during healthy human pregnancy. Clin Exp Immunol 164 (2011), 180–192.
25. Ueda, Y, Hagihara, M, Okamoto, A, et al. Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. Hum Immunol 64 (2003), 1144–1151.
26. Young, BC, Stanic, AK, Panda, B, Rueda, BR, Panda, A, Longitudinal expression of toll-like receptors on dendritic cells in uncomplicated pregnancy and postpartum. Am J Obstet Gynecol, 210, 2014, 445.
27. Klein, SL, Flanagan, KL, Sex differences in immune responses. Nat Rev Immunol 16 (2016), 626–638.
28. Healy, CM, Rench, MA, Baker, CJ, Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunisation and protection of young infants. Clin Infect Dis 56 (2013), 539–544.
29. Sperling, RS, Engel, SM, Wallenstein, S, et al. Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol 119 (2012), 631–639.
30. Gupta, I, Ratho, RK, Immunogenicity and safety of two schedules of hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res 29 (2003), 84–86.
31. Baker, CJ, Rench, MA, McInnes, P, Immunisation of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 21 (2003), 3468–3472.
32. Hulka, JF, Effectiveness of polyvalent influenze vaccine in pregnancy. Report of a controlled study during an outbreak of Asian influenza. Obstet Gynecol 23 (1964), 830–837.
33. Murray, DL, Imagawa, DT, Okada, DM, St Geme, JW, Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. J Clin Microbiol 10 (1979), 184–187.
34. Schlaudecker, EP, McNeal, MM, Dodd, CN, Ranz, JB, Steinhoff, MC, Pregnancy modifies the antibody response to trivalent influenza immunisation. J Infect Dis 206 (2012), 1670–1673.
35. Bischoff, AL, Følsgaard, NV, Carson, CG, et al. Altered response to A(H1N1)pnd09 vaccination in pregnant women: a single blinded randomized controlled trial. PLoS One, 8, 2013, e56700.
36. Kay, AW, Bayless, NL, Fukuyama, J, et al. Pregnancy does not attenuate the antibody or plasmablast response to inactivated influenza vaccine. J Infect Dis 212 (2015), 861–870.
37. Munoz, FM, Bond, NH, Maccato, M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunisation during pregnancy in mothers and infants: a randomized clinical trial. JAMA 311 (2014), 1760–1769.
38. Huygen, K, Cabore, RN, Maertens, K, Van Damme, P, Leuridan, E, Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women. Vaccine 33 (2015), 4117–4123.
39. Brabin, BJ, Nagel, J, Hagenaars, AM, Ruitenberg, E, van Tilborgh, AM, The influence of malaria and gestation on the immune response to one and two doses of adsorbed tetanus toxoid in pregnancy. Bull World Health Organ 62 (1984), 919–930.
40. Hardegree, MC, Barile, MF, Pittman, M, Schofield, FD, Maclennan, R, Kelly, A, Immunisation against neonatal tetanus in New Guinea. Bull World Health Organ 43 (1970), 439–451.
41. Madhi, SA, Cutland, CL, Jose, L, et al. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis 16 (2016), 923–934.
42. Ohfuji, S, Fukushima, W, Deguchi, M, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 203 (2011), 1301–1308.
43. Abu Raya, B, Bamberger, E, Almog, M, Peri, R, Srugo, I, Kessel, A, Immunisation of pregnant women against pertussis: the effect of timing on antibody avidity. Vaccine 33 (2015), 1948–1952.
44. Maertens, K, Hoang, THT, Caboré, RN, Leuridan, E, Avidity of maternal pertussis antibodies after vaccination during pregnancy. Vaccine, 33, 2015, 5489.
45. Centers for Disease Contol and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 62 (2013), 131–135.
46. Eberhardt, CS, Blanchard-Rohner, G, Lemaître, B, et al. Maternal immunisation earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin Infect Dis 62 (2016), 829–836.
47. Christian, LM, Porter, K, Karlsson, E, Schultz-Cherry, S, Iams, JD, Serum proinflammatory cytokine responses to influenza virus vaccine among women during pregnancy versus non-pregnancy. Am J Reprod Immunol 70 (1989), 45–53.
48. Regan, AK, Tracey, L, Blyth, CC, et al. A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women. BMC Pregnancy Childbirth, 15, 2015, 61.
49. Gandhi, M, Devaraj, S, Sangi-Haghpeykar, H, Mastrobattista, J, The effect of body mass index on post-vaccination maternal and neonatal pertussis antibody levels. J Reprod Immunol 112 (2015), 34–37.
50. Jones, CE, Naidoo, S, De Beer, C, Esser, M, Kampmann, B, Hesseling, AC, Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 305 (2011), 576–584.
51. van den Berg, JP, Westerbeek, EA, Berbers, GA, van Gageldonk, PG, van der Klis, FR, van Elburg, RM, Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, Haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J 29 (2010), 801–805.
52. Mulholland, K, Suara, RO, Siber, G, et al. Maternal immunisation with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. JAMA 275 (1996), 1182–1188.
53. Maertens, K, Caboré, RN, Huygen, K, Hens, N, Van Damme, P, Leuridan, E, Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study. Vaccine 34 (2016), 142–150.
54. Cavalcante, RS, Kopelman, BI, Costa-Carvalho, BT, Placental transfer of Haemophilus influenzae type b antibodies in malnourished pregnant women. Braz J Infect Dis 12 (2008), 47–51.
55. Siddiqua, TJ, Ahmad, SM, Ahsan, KB, et al. Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh. Eur J Nutr 55 (2016), 281–293.
56. Madhi, SA, Cutland, CL, Kuwanda, L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 371 (2014), 918–931.
57. Nunes, MC, Cutland, CL, Dighero, B, et al. Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants. J Infect Dis 212 (2015), 1976–1987.
58. Heyderman, RS, Madhi, SA, French, N, et al. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis 16 (2016), 546–555.
59. McSorley, HJ, Maizels, RM, Helminth infections and host immune regulation. Clin Microbiol Rev 25 (2012), 585–608.
60. Simister, NE, Placental transport of immunoglobulin G. Vaccine 21 (2003), 3365–3369.
61. Bundhoo, A, Paveglio, S, Rafti, E, Dhongade, A, Blumberg, RS, Matson, AP, Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes. Clin Exp Allergy 45 (2015), 1085–1098.
62. Stapleton, NM, Einarsdóttir, HK, Stemerding, AM, Vidarsson, G, The multiple facets of FcRn in immunity. Immunol Rev 268 (2015), 253–268.
63. Roopenian, DC, Akilesh, S, FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7 (2007), 715–725.
64. Firan, M, Bawdon, R, Radu, C, et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int Immunol 13 (2001), 993–1002.
65. Malek, A, Sager, R, Kuhn, P, Nicolaides, KH, Schneider, H, Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 36 (1996), 248–255.
66. Heininger, U, Riffelmann, M, Leineweber, B, Wirsing von Koenig, CH, Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns. Pediatr Infect Dis J 28 (2009), 443–445.
67. van den Berg, JP, Westerbeek, EA, van der Klis, FR, Berbers, GA, van Elburg, RM, Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev 87 (2011), 67–72.
68. van den Berg, JP, Westerbeek, EAM, Smits, GP, van der Klis, FRM, Berbers, GAM, van Elburg, RM, Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants. PLoS One, 9, 2014, e94714.
69. Palmeira, P, Quinello, C, Silveira-Lessa, AL, Zago, CA, Carneiro-Sampaio, M, IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol, 2012, 2012, 985646.
70. Blencowe, H, Cousens, S, Oestergaard, MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379 (2012), 2162–2172.
71. Garty, BZ, Ludomirsky, A, Danon, YL, Peter, JB, Douglas, SD, Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol 1 (1994), 667–669.
72. Vidarsson, G, Dekkers, G, Rispens, T, IgG subclasses and allotypes: from structure to effector functions. Front Immunol, 5, 2014, 520.
73. de Voer, RM, van der Klis, FR, Nooitgedagt, JE, et al. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis. Clin Infect Dis 49 (2009), 58–64.
74. Leineweber, B, Grote, V, Schaad, UB, Heininger, U, Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J 23 (2004), 361–363.
75. Munoz, FM, Englund, JA, Cheesman, CC, et al. Maternal immunisation with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 20 (2001), 826–837.
76. Lin, FY, Weisman, LE, Azimi, PH, et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis 190 (2004), 928–934.
77. Baker, CJ, Carey, VJ, Rench, MA, et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis 209 (2014), 781–788.
78. Steinhoff, MC, Omer, SB, Roy, E, et al. Influenza immunisation in pregnancy—antibody responses in mothers and infants. N Engl J Med 362 (2010), 1644–1646.
79. Avanzini, MA, Pignatti, P, Chirico, G, Gasparoni, A, Jalil, F, Hanson, LA, Placental transfer favours high avidity IgG antibodies. Acta Paediatr 87 (1998), 180–185.
80. Sennhauser, FH, Balloch, A, Macdonald, RA, Shelton, MJ, Roberton, DM, Maternofetal transfer of IgG anti-Escherichia coli antibodies with enhanced avidity and opsonic activity in very premature neonates. Pediatr Res 27 (1990), 365–371.
81. Williams, PJ, Arkwright, PD, Rudd, P, et al. Short communication: selective placental transport of maternal IgG to the fetus. Placenta 16 (1995), 749–756.
82. Einarsdottir, HK, Selman, MHJ, Kapur, R, et al. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj J 30 (2013), 147–157.
83. Hartter, HK, Oyedele, OI, Dietz, K, Kreis, S, Hoffman, JP, Muller, CP, Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect J 19 (2000), 635–641.
84. Okoko, BJ, Wesumperuma, LH, Ota, MO, et al. The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural west African population. J Infect Dis 184 (2001), 627–632.
85. Cumberland, P, Shulman, CE, Maple, PA, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 196 (2007), 550–557.
86. Atwell, JE, Thumar, B, Robinson, LJ, et al. Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea. J Infect Dis 213 (2016), 423–431.
87. Dangor, Z, Kwatra, G, Izu, A, et al. HIV-1 Is associated with lower group B streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women. J Infect Dis 212 (2015), 453–462.
88. Le Doare, K, Taylor, S, Allen, L, et al. Placental transfer of anti-group B streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants. AIDS 30 (2016), 471–475.
89. Abu-Raya, B, Smolen, KK, Willems, F, Kollmann, TR, Marchant, A, Transfer of maternal antimicrobial immunity to HIV-exposed uninfected newborns. Front Immunol, 7, 2016, 338.
90. Bahl, R, Frost, C, Kirkwood, BR, et al. Infant feeding patterns and risks of death and hospitalization in the first half of infancy: multicentre cohort study. Bull World Health Organ 83 (2005), 418–426.
91. Victora, CG, Bahl, R, Barros, AJ, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387 (2016), 475–490.
92. Schlaudecker, EP, Steinhoff, MC, Omer, SB, et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunisation. PLoS One, 8, 2013, e70867.
93. Brandtzaeg, P, Mucosal immunity: integration between mother and the breast-fed infant. Vaccine 21 (2003), 3382–3388.
94. Fouda, GG, Amos, JD, Wilks, AB, et al. Mucosal immunisation of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk. J Virol 87 (2013), 6986–6999.
95. Corthesy, B, Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol, 4, 2013, 185.
96. Ogra, SS, Weintraub, D, Ogra, PL, Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn. J Immunol 119 (1977), 245–248.
97. Vukavic, T, Intestinal absorption of IgA in the newborn. J Pediatr Gastroenterol Nutr 2 (1983), 248–251.
98. Moon, SS, Wang, Y, Shane, AL, et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J 29 (2010), 919–923.
99. Rongsen-Chandola, T, Strand, TA, Goyal, N, et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in north Indian infants. Vaccine 32:suppl 1 (2014), A134–A139.
100. Maertens, K, De Schutter, S, Braeckman, T, et al. Breastfeeding after maternal immunisation during pregnancy: providing immunological protection to the newborn: a review. Vaccine 32 (2014), 1786–1792.
101. Pollara, J, McGuire, E, Fouda, GG, et al. Association of HIV-1 envelope-specific breast milk IgA responses with reduced risk of postnatal mother-to-child transmission of HIV-1. J Virol 89 (2015), 9952–9961.
102. Castellote, C, Casillas, R, Ramirez-Santana, C, et al. Premature delivery influences the immunological composition of colostrum and transitional and mature human milk. J Nutr 141 (2011), 1181–1187.
103. Ballard, O, Morrow, AL, Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am 60 (2013), 49–74.
104. Shapiro, RL, Lockman, S, Kim, S, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis 196 (2007), 562–569.
105. Moussa, S, Jenabian, MA, Gody, JC, et al. Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding. PLoS One, 8, 2013, e63408.
106. Brussow, H, Barclay, D, Sidoti, J, et al. Effect of malnutrition on serum and milk antibodies in Zairian women. Clin Diagn Lab Immunol 3 (1996), 37–41.
107. Islam, SK, Ahmed, L, Khan, MN, Huque, S, Begum, A, Yunus, AB, Immune components (IgA, IgM, IgG, immune cells) of colostrum of Bangladeshi mothers. Pediatr Int 48 (2006), 543–548.
108. Tuaillon, E, Valea, D, Becquart, P, et al. Human milk-derived B cells: a highly activated switched memory cell population primed to secrete antibodies. J Immunol 182 (2009), 7155–7162.
109. Hurley, WL, Theil, PK, Perspectives on immunoglobulins in colostrum and milk. Nutrients 3 (2011), 442–474.
110. Gao, X, McMahon, RJ, Woo, JG, Davidson, BS, Morrow, AL, Zhang, Q, Temporal changes in milk proteomes reveal developing milk functions. J Proteome Res 11 (2012), 3897–3907.
111. Edwards, MS, Munoz, FM, Baker, CJ, Antibodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infect Dis J 23 (2004), 961–963.
112. Mabuka, J, Nduati, R, Odem-Davis, K, Peterson, D, Overbaugh, J, HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads. PLoS Pathog, 8, 2012, e1002739.
113. Ehlinger, EP, Webster, EM, Kang, HH, et al. Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants. J Infect Dis 204 (2011), 1672–1682.
114. Yoshida, M, Claypool, SM, Wagner, JS, et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20 (2004), 769–783.
115. Yoshida, M, Kobayashi, K, Kuo, TT, et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 116 (2006), 2142–2151.
116. Harris, NL, Spoerri, I, Schopfer, JF, et al. Mechanisms of neonatal mucosal antibody protection. J Immunol 177 (2006), 6256–6262.
117. Baker, K, Qiao, SW, Kuo, T, et al. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin Immunopathol 31 (2009), 223–236.
118. Wirt, DP, Adkins, LT, Palkowetz, KH, Schmalstieg, FC, Goldman, AS, Activated and memory T lymphocytes in human milk. Cytometry 13 (1992), 282–290.
119. Hassiotou, F, Geddes, DT, Hartmann, PE, Cells in human milk: state of the science. J Hum Lact 29 (2013), 171–182.
120. Wilks, AB, Christian, EC, Seaman, MS, et al. Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys. J Immunol 185 (2010), 7097–7106.
121. Mahlokozera, T, Kang, HH, Goonetilleke, N, et al. The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk. PLoS One, 6, 2011, e23735.
122. Mohr, JA, The possible induction and-or acquisition of cellular hypersensitivity associated with ingestion of colostrum. J Pediatr 82 (1973), 1062–1064.
123. Schlesinger, JJ, Covelli, HD, Evidence for transmission of lymphocyte responses to tuberculin by breast-feeding. Lancet 2 (1977), 529–532.
124. Lawrence, RM, Lawrence, RA, Breast milk and infection. Clin Perinatol 31 (2004), 501–528.
125. John-Stewart, GC, Mbori-Ngacha, D, Payne, BL, et al. HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission. J Infect Dis 199 (2009), 889–898.
126. Qureshi, K, Molbak, K, Sandstrom, A, et al. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau. Pediatr Infect Dis J 25 (2006), 1163–1166.
127. Alain, S, Dommergues, MA, Jacquard, AC, Caulin, E, Launay, O, State of the art: could nursing mothers be vaccinated with attenuated live virus vaccine?. Vaccine 30 (2012), 4921–4926.
128. Verhasselt, V, Is infant immunisation by breastfeeding possible?. Philos Trans R Soc Lond B Biol Sci, 370, 2015, 20140139.
129. Wan, AK, Seow, WK, Purdie, DM, Bird, PS, Walsh, LJ, Tudehope, DI, Immunoglobulins in saliva of preterm and full-term infants. Oral Microbiol Immunol 18 (2003), 72–78.
130. Morris, D, McDonald, JC, Failure of hyperimmune gamma globulin to prevent whooping cough. Arch Dis Child 32 (1957), 236–239.
131. Kirimanjeswara, GS, Mann, PB, Harvill, ET, Role of antibodies in immunity to bordetella infections. Infect Immun 71 (2003), 1719–1724.
132. Warfel, JM, Zimmerman, LI, Merkel, TJ, Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA 111 (2014), 787–792.
133. Dabrera, G, Amirthalingam, G, Andrews, N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013. Clin Infect Dis 60 (2015), 333–337.
134. Zinkernagel, RM, Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 345 (2001), 1331–1335.
135. Ghetie, V, Ward, ES, Transcytosis and catabolism of antibody. Immunol Res 25 (2002), 97–113.
136. Gutierrez, G, Gentile, T, Miranda, S, Margni, RA, Asymmetric antibodies: a protective arm in pregnancy. Chem Immunol Allergy 89 (2005), 158–168.
137. Sarvas, H, Seppälä, I, Kurikka, S, Siegberg, R, Mäkelä, O, Half-life of the maternal IgG1 allotype in infants. J Clin Immunol 13 (1993), 145–151.
138. Healy, CM, Munoz, FM, Rench, MA, Halasa, NB, Edwards, KM, Baker, CJ, Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 190 (2004), 335–340.
139. Caceres, VM, Strebel, PM, Sutter, RW, Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis 31 (2000), 110–119.
140. Ochola, R, Sande, C, Fegan, G, et al. The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya. PLoS One, 4, 2009, e8088.
141. Chu, HY, Steinhoff, MC, Magaret, A, et al. Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh. J Infect Dis 210 (2014), 1582–1589.
142. Siegrist, CA, Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 21 (2003), 3406–3412.
143. Niewiesk, S, Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol, 5, 2014, 446.
144. Faucette, AN, Unger, BL, Gonik, B, Chen, K, Maternal vaccination: moving the science forward. Hum Reprod Update 21 (2015), 119–135.
145. Nair, N, Gans, H, Lew-Yasukawa, L, Long-Wagar, AC, Arvin, A, Griffin, DE, Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. J Infect Dis 196 (2007), 1339–1345.
146. Van Savage, J, Decker, MD, Edwards, KM, Sell, SH, Karzon, DT, Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 161 (1990), 487–492.
147. Englund, JA, Anderson, EL, Reed, GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunisation with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 96 (1995), 580–584.
148. Mooi, FR, de Greeff, SC, The case for maternal vaccination against pertussis. Lancet Infect Dis 7 (2007), 614–624.
149. Ladhani, SN, Andrews, NJ, Southern, J, et al. Antibody responses after primary immunisation in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis 61 (2015), 1637–1644.
150. Hoang, HTT, Leuridan, E, Maertens, K, et al. Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial pertussis vaccination during pregnancy. Vaccine 34 (2016), 151–159.
151. Edwards, KM, Pertussis: an important target for maternal immunisation. Vaccine 21 (2003), 3483–3486.
152. Barington, T, Gyhrs, A, Kristensen, K, Heilmann, C, Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 62 (1994), 9–14.
153. Englund, JA, Glezen, WP, Turner, C, Harvey, J, Thompson, C, Siber, GR, Transplacental antibody transfer following maternal immunisation with polysaccharide and conjugate Haemophilus influenzae type b vaccines. J Infect Dis 171 (1995), 99–105.
154. Kurikka, S, Olander, RM, Eskola, J, Käyhty, H, Passively acquired anti-tetanus and anti-haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. Pediatr Infect Dis J 15 (1996), 530–535.
155. Rastogi, D, Wang, C, Mao, X, Lendor, C, Rothman, PB, Miller, RL, Antigen-specific immune responses to influenza vaccine in utero. J Clin Invest 117 (2007), 1637–1646.
156. Vanderbeeken, Y, Sarfati, M, Bose, R, Delespesse, G, In utero immunisation of the fetus to tetanus by maternal vaccination during pregnancy. Am J Reprod Immunol Microbiol 8 (1985), 39–42.
157. Gill, TJ 3rd, Repetti, CF, Metlay, LA, et al. Transplacental immunisation of the human fetus to tetanus by immunisation of the mother. J Clin Invest 72 (1983), 987–996.
158. Aaby, P, Kollmann, TR, Benn, CS, Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol 15 (2014), 895–899.
159. Bischoff, AL, Folsgaard, NV, Vissing, NH, Birch, S, Brix, S, Bisgaard, H, Airway mucosal immune-suppression in neonates of mothers receiving A(H1N1)pnd09 vaccination during pregnancy. Pediatr Infect Dis J 30 (2014), 84–90.